Karin Jirström

Person

Limhamn, SE

People

Patents Grantslast 30 patents

Information Patent Grant
RBM3 in bladder cancer
- Patent number 9,701,741
- Issue date Jul 11, 2017
- Atlas Antibodies AB
- Jakob Eberhard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RBM3 protein in colorectal cancer prognostics
- Patent number 9,416,176
- Issue date Aug 16, 2016
- Atlas Antibodies AB
- Mathias Uhlén
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PODXL in bladder cancer
- Patent number 9,354,232
- Issue date May 31, 2016
- Atlas Antibodies AB
- Karin Jirstrom
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PODXL protein in colorectal cancer
- Patent number 8,999,656
- Issue date Apr 7, 2015
- Atlas Antibodies AB
- Karin Jirström
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment prediction involving HMGCR
- Patent number 8,945,832
- Issue date Feb 3, 2015
- Atlas Antibodies AB
- Mathias Uhlen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Prediction of response to platinum-based therapy
- Patent number 8,747,910
- Issue date Jun 10, 2014
- Atlas Antibodies AB
- Karin Jirström
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RBM3 in colorectal cancer prognostics
- Patent number 8,728,739
- Issue date May 20, 2014
- Atlas Antibodies AB
- Mathias Uhlén
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RBM3 as a marker for malignant melanoma prognosis
- Patent number 8,632,984
- Issue date Jan 21, 2014
- Atlas Antibodies AB
- Mathias Uhlén
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Epitopes derived from SATB2 and uses thereof
- Patent number 8,420,788
- Issue date Apr 16, 2013
- Atlas Antibodies AB
- Karin Jirström
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PODXL IN BLADDER CANCER
- Publication number 20150309030
- Publication date Oct 29, 2015
- ATLAS ANTIBODIES AB
- Karin Jirstrom
- G01 - MEASURING TESTING
Information Patent Application
PODXL PROTEIN IN COLORECTAL CANCER
- Publication number 20150309033
- Publication date Oct 29, 2015
- ATLAS ANTIBODIES AB
- Karin Jirström
- G01 - MEASURING TESTING
Information Patent Application
RBM3 Protein in Colorectal Cancer Prognostics
- Publication number 20140295462
- Publication date Oct 2, 2014
- ATLAS ANTIBODIES AB
- Mathias Uhlen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RBM3 in Bladder Cancer
- Publication number 20140170676
- Publication date Jun 19, 2014
- ATLAS ANTIBODIES AB
- Jakob Eberhard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RBM3 as a Marker for Malignant Melanoma Prognosis
- Publication number 20120269764
- Publication date Oct 25, 2012
- ATLAS ANTIBODIES AB
- Mathias Uhlén
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PODXL Protein in Colorectal Cancer
- Publication number 20120219548
- Publication date Aug 30, 2012
- Atlas Antibodies AB
- Karin Jirström
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Means and Method for Ovarian Cancer Prognosis
- Publication number 20120058202
- Publication date Mar 8, 2012
- Mathias Uhlén
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Treatment of Breast Cancer
- Publication number 20120053196
- Publication date Mar 1, 2012
- Karin Jirström
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RBM3 in Testicular Cancer Diagnostics and Prognostics
- Publication number 20120040338
- Publication date Feb 16, 2012
- Atlas Antibodies AB
- Karin Jirström
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Prediction of Response to Platinum-Based Therapy
- Publication number 20120034317
- Publication date Feb 9, 2012
- Karin Jirström
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RBM3 in Colorectal Cancer Prognostics
- Publication number 20120034218
- Publication date Feb 9, 2012
- Atlas Antibodies AB
- Mathias Uhlen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANLN PROTEIN AS AN ENDOCRINE TREATMENT PREDICTIVE FACTOR
- Publication number 20110269797
- Publication date Nov 3, 2011
- ATLAS ANTIBODIES AB
- Mathias Uhlén
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT PREDICTION INVOLVING HMGCR
- Publication number 20110142828
- Publication date Jun 16, 2011
- ATLAS ANTIBODIES AB
- Mathias UHLEN
- G01 - MEASURING TESTING
Information Patent Application
BREAST CANCER PROGNOSTICS
- Publication number 20110144198
- Publication date Jun 16, 2011
- ATLAS ANTIBODIES AB
- Mathias Uhlén
- G01 - MEASURING TESTING
Information Patent Application
RBM3 AS A MARKER FOR BREAST CANCER PROGNOSIS
- Publication number 20110021635
- Publication date Jan 27, 2011
- Mathias Uhlen
- G01 - MEASURING TESTING
Information Patent Application
BREAST CANCER TREATMENT AND TREATMENT PREDICTION
- Publication number 20110003854
- Publication date Jan 6, 2011
- Fredrik Ponten
- G01 - MEASURING TESTING
Information Patent Application
DIAGNOSIS OF TAMOXIFEN SENSITIVITY
- Publication number 20080003606
- Publication date Jan 3, 2008
- Goran Landberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Karin Jirström

Person

Patents Grantslast 30 patents

RBM3 in bladder cancer

RBM3 protein in colorectal cancer prognostics

PODXL in bladder cancer

PODXL protein in colorectal cancer

Treatment prediction involving HMGCR

Prediction of response to platinum-based therapy

RBM3 in colorectal cancer prognostics

RBM3 as a marker for malignant melanoma prognosis

Epitopes derived from SATB2 and uses thereof

Patents Applicationslast 30 patents

PODXL IN BLADDER CANCER

PODXL PROTEIN IN COLORECTAL CANCER

RBM3 Protein in Colorectal Cancer Prognostics

RBM3 in Bladder Cancer

RBM3 as a Marker for Malignant Melanoma Prognosis

PODXL Protein in Colorectal Cancer

Means and Method for Ovarian Cancer Prognosis

Combination Treatment of Breast Cancer

RBM3 in Testicular Cancer Diagnostics and Prognostics

Prediction of Response to Platinum-Based Therapy

RBM3 in Colorectal Cancer Prognostics

ANLN PROTEIN AS AN ENDOCRINE TREATMENT PREDICTIVE FACTOR

TREATMENT PREDICTION INVOLVING HMGCR

BREAST CANCER PROGNOSTICS

RBM3 AS A MARKER FOR BREAST CANCER PROGNOSIS

BREAST CANCER TREATMENT AND TREATMENT PREDICTION

DIAGNOSIS OF TAMOXIFEN SENSITIVITY